Latest Wave Life Sciences News & Updates

See the latest news and media coverage for Wave Life Sciences. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Wave Life Sciences

RNA medicines developer

wavelifesciences.com
Headquarters
Cambridge, United States
Founded year
2012
Company type
Public company
Number of employees
350–500
Industry
Pharmaceuticals

Last updated

Latest news about Wave Life Sciences

In short: Wave Life Sciences advanced its clinical pipeline, initiated Phase 2a obesity trials for WVE-007, and secured a cash runway into Q3 2028.

Company announcements

Wave Life Sciences

Wave Life Sciences reports WVE-006 achieves MZ-like phenotype

WVE-006 showed 64% wild-type M-AAT, 71% reduction in Z-AAT, and sustained editing up to three months post-dose.

Unlock all announcements with a

Media coverage

Markets Insider

Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation

As previously announced, Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human...

Unlock all articles with a

Never miss news about Wave Life Sciences

Track Wave Life Sciences and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Wave Life Sciences competitors & trending companies

Browse news for competitors to Wave Life Sciences and other trending companies.